A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults
Public ClinicalTrials.gov record NCT07768345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 3, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF REVACCINATION WITH RESPIRATORY SYNCYTIAL VIRUS STABILIZED PREFUSION F SUBUNIT VACCINE (RSVPREF) IN IMMUNOCOMPROMISED ADULTS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this phase 3 study is to learn the safety, tolerability and immunogenicity of revaccination with RSVpreF at approximately 1-, 2-, and 3-year intervals to inform the revaccination interval in immunocompromised adults. This study is seeking participants who are 18 years of age and older and will be grouped based on prior RSV vaccination history. Participants are required to be immunocompromised per study protocol. All participants in this study will receive 1 shot to their arm of a RSVPreF vaccine. Participants will take part in this study for about 12 months and will need to visit the clinical study site at least 4 times.
Study identification
- NCT ID
- NCT07768345
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 440 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2026 (Actual)
- Primary completion
- Feb 2, 2028 (Estimated)
- Completion
- Feb 2, 2028 (Estimated)
- Last update posted
- Oct 14, 2026
2026 – 2028
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Foundation Hospital LAMC | Los Angeles | California | 90027 | Recruiting |
| Kaiser Permanente Los Angeles Medical center | Los Angeles | California | 90027 | Recruiting |
| Kaiser Permanente | Los Angeles | California | 90027 | Recruiting |
| George Washington University | Washington D.C. | District of Columbia | 20037 | Recruiting |
| The Hope Clinic of Emory University | Decatur | Georgia | 30030 | Recruiting |
| University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| University of Iowa, Infectious Disease Research Laboratory, VA Medical Center | Iowa City | Iowa | 52246 | Recruiting |
| University of Maryland, Institute of Human Virology | Baltimore | Maryland | 21201 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Recruiting |
| NYU Langone Health Vaccine Center | New York | New York | 10016 | Recruiting |
| Rochester Clinical Research | Rochester | New York | 14609 | Recruiting |
| University of Rochester Investigational Drug Services | Rochester | New York | 14642 | Not yet recruiting |
| University of Rochester Medical Center-Infectious Diseases Research Clinic | Rochester | New York | 14642 | Not yet recruiting |
| Duke Vaccine and Trials Unit | Durham | North Carolina | 27703 | Not yet recruiting |
| Duke Clinics 2F, 2G | Durham | North Carolina | 27710 | Not yet recruiting |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | Recruiting |
| Epic Medical Research-Desoto | DeSoto | Texas | 75115 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07768345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07768345 live on ClinicalTrials.gov.